Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke

Dao-Fu Dai; Peterus Thajeb; Cheng-Fen Tu; Fu-Tien Chiang; Chien-Hsiun Chen; Ruey-Bing Yang; Jin-Jer Chen

doi:10.1016/j.jacc.2008.01.060

Back

Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke

Journal article

Open access

Peer reviewed

Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke

Dao-Fu Dai, Peterus Thajeb, Cheng-Fen Tu, Fu-Tien Chiang, Chien-Hsiun Chen, Ruey-Bing Yang and Jin-Jer Chen

Journal of the American College of Cardiology, Vol.51(22), pp.2173-2180

06/03/2008

DOI: 10.1016/j.jacc.2008.01.060

PMID: 18510966

Files and links (1)

url

https://doi.org/10.1016/j.jacc.2008.01.060View

Published (Version of record) Open Access

Abstract

This study investigates the potential application of plasma SCUBE1 [signal peptide-CUB (complement C1r/C1s, Uegf, and Bmp1)-EGF (epidermal growth factor)-like domain-containing protein 1] as a biomarker of platelet activation in acute coronary syndrome (ACS) and acute ischemic stroke (AIS). Platelet activation plays a crucial role in ACS and AIS. Platelet stimulation is associated with increased plasma concentration of SCUBE1, a novel platelet-endothelial secreted protein identified in our previous study. Plasma concentrations of SCUBE1 from 40 ACS and 40 AIS patients were measured by enzyme-linked immunoadsorbent assay and compared with the levels of 40 healthy control subjects and 83 chronic coronary artery disease (CAD) patients. Two-dimensional electrophoresis followed by Western blotting was used to characterize SCUBE1 protein in patients' plasma. Plasma SCUBE1 concentration was virtually undetectable in healthy control subjects and CAD patients, but was significantly higher in ACS and AIS patients (median = 205 and 95.1 ng/ml, respectively, p < 0.01). The increase in plasma SCUBE1 was detectable in the plasma as early as 6 h after the onset of symptoms and remained detectable up to 84 h. Plasma SCUBE1 concentration is an independent predictor of stroke severity based on National Institutes of Health Stroke Scale (beta = 3.18, p < 0.001). Furthermore, smaller SCUBE1 fragments were detected in ACS patients' plasma, suggesting that plasma SCUBE1 might subject to a proteolytic regulation under pathological conditions. Plasma SCUBE1 concentration is significantly elevated in ACS and AIS but not CAD patients. Plasma SCUBE1 is a potential biomarker of platelet activation in acute thrombotic disease.

Brain Ischemia - complications

Prognosis

Enzyme-Linked Immunosorbent Assay

Humans

Middle Aged

Blood Platelets

Acute Coronary Syndrome - physiopathology

Male

Biomarkers - blood

Stroke - physiopathology

Case-Control Studies

Acute Coronary Syndrome - blood

Platelet Aggregation

Stroke - blood

Pilot Projects

Stroke - etiology

Platelet Activation

Female

Membrane Proteins - blood

Details

Title: Subtitle: Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke
Creators: Dao-Fu Dai - Section of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan
Peterus Thajeb
Cheng-Fen Tu
Fu-Tien Chiang
Chien-Hsiun Chen
Ruey-Bing Yang
Jin-Jer Chen
Resource Type: Journal article
Publication Details: Journal of the American College of Cardiology, Vol.51(22), pp.2173-2180
DOI: 10.1016/j.jacc.2008.01.060
PMID: 18510966
NLM abbreviation: J Am Coll Cardiol
ISSN: 0735-1097
eISSN: 1558-3597
Publisher: United States
Language: English
Date published: 06/03/2008
Academic Unit: Pathology; Iowa Neuroscience Institute; Radiation Oncology
Record Identifier: 9984046917002771

Metrics

25 Record Views

104 Times Cited - Web of Science